We are live on ! Find out more
LS

Leelyn Smith Portfolio holdings

AUM $822M Turnover 11.52%
1-Year Est. Return 31.69%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+31.69%
3 Year Est. Return
+77.34%
5 Year Est. Return
+91.98%
10 Year Est. Return
–
AUM
$336M
AUM Growth
+$23.3M
Cap. Flow
+$15.2M
Cap. Flow %
4.53%
Top 10 Hldgs %
40.79%
Holding
397
New
32
Increased
145
Reduced
77
Closed
9
Avg Time Held
0.9 years
Top 10 Avg Time Held
0.9 years
Top 20 Avg Time Held
1 year

Sector Composition

Rank Sector Weight
1 Miscellaneous 52.04%
2 Technology 10.61%
3 Healthcare 7.68%
4 Consumer Discretionary 7.22%
5 Financials 5.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CVS icon
326
CVS Health
CVS
$118B
$5K ﹤0.01%
65
-655
-91% -$47.7K
2020 Q1
4 quarters
DELL icon
327
Dell
DELL
$301B
$5K ﹤0.01%
116
– –
2020 Q4
1 quarter
GILD icon
328
Gilead Sciences
GILD
$195B
$5K ﹤0.01%
79
– –
2020 Q3
2 quarters
KOPN icon
329
Kopin
KOPN
$688M
$5K ﹤0.01%
+455
New +$3.44K
2021 Q1
0 quarters
SNOW icon
330
Snowflake
SNOW
$118B
$5K ﹤0.01%
22
– –
2020 Q3
2 quarters
THS icon
331
DELISTED
Treehouse Foods
THS
$5K ﹤0.01%
100
– –
2019 Q4
5 quarters
MFC icon
332
Manulife Financial
MFC
$72.6B
$4K ﹤0.01%
164
– –
2019 Q4
5 quarters
ORCL icon
333
Oracle
ORCL
$408B
$4K ﹤0.01%
51
+1
+2% +$65
2019 Q4
5 quarters
VFC icon
334
VF Corp
VFC
$6.68B
$4K ﹤0.01%
56
+1
+2% +$81
2019 Q4
5 quarters
VSS icon
335
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.4B
$4K ﹤0.01%
28
– –
2019 Q4
5 quarters
XLE icon
336
State Street Energy Select Sector SPDR ETF
XLE
$42.8B
$4K ﹤0.01%
144
– –
2019 Q4
5 quarters
BWX icon
337
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.29B
$3K ﹤0.01%
109
-4
-4% -$121
2020 Q1
4 quarters
DD icon
338
DuPont de Nemours
DD
$17.8B
$3K ﹤0.01%
28
– –
2020 Q4
1 quarter
EWC icon
339
iShares MSCI Canada ETF
EWC
$7.28B
$3K ﹤0.01%
91
-63
-41% -$2.06K
2020 Q1
4 quarters
FTNT icon
340
Fortinet
FTNT
$133B
$3K ﹤0.01%
75
– –
2019 Q4
5 quarters
GLDM icon
341
SPDR Gold MiniShares Trust
GLDM
$31B
$3K ﹤0.01%
90
+6
+7% +$214
2020 Q3
2 quarters
HUM icon
342
Humana
HUM
$51.9B
$3K ﹤0.01%
7
– –
2020 Q2
3 quarters
JMIA icon
343
Jumia Technologies
JMIA
$816M
$3K ﹤0.01%
+76
New +$3.64K
2021 Q1
0 quarters
TEL icon
344
TE Connectivity
TEL
$61.7B
$3K ﹤0.01%
26
– –
2020 Q4
1 quarter
USHY icon
345
iShares Broad USD High Yield Corporate Bond ETF
USHY
$25.4B
$3K ﹤0.01%
64
-1
-2% -$41
2019 Q4
5 quarters
WRAP icon
346
Wrap Technologies
WRAP
$84M
$3K ﹤0.01%
500
– –
2020 Q4
1 quarter
XSLV icon
347
Invesco S&P SmallCap Low Volatility ETF
XSLV
$233M
$3K ﹤0.01%
63
– –
2019 Q4
5 quarters
BNTX icon
348
BioNTech
BNTX
$22.7B
$2K ﹤0.01%
+20
New +$2.12K
2021 Q1
0 quarters
CTVA icon
349
Corteva
CTVA
$8.59B
$2K ﹤0.01%
35
– –
2020 Q4
1 quarter
DOW icon
350
Dow Inc
DOW
$21.4B
$2K ﹤0.01%
35
– –
2020 Q4
1 quarter

Similar funds

Leelyn Smith's Q1 2021 Portfolio in Review

As of Q1 2021, Leelyn Smith held 397 positions worth $336M, up 7.4% from $313M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Leelyn Smith deployed $15.2M of net new capital in Q1 2021, opening 32 new positions and adding to 145 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 4,717 shares worth $1.01M.

By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 52% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Charles Schwab, an estimated $2.01M trimmed.

  • Leelyn Smith's largest Q1 2021 buy was Vertex Pharmaceuticals: 4,717 shares worth $1.01M.
  • Leelyn Smith added most to Invesco QQQ Trust in Q1 2021, an estimated $2.55M increase.
  • Leelyn Smith's biggest Q1 2021 reduction was Charles Schwab, cutting an estimated $2.01M.
  • Leelyn Smith fully exited Colgate-Palmolive in Q1 2021, selling an estimated $94K.
  • Leelyn Smith's ten largest holdings make up 41% of its $336M portfolio in Q1 2021.
  • Leelyn Smith opened 32 new positions and closed 9 in Q1 2021.
  • Leelyn Smith's portfolio value rose 7.4% quarter-over-quarter to $336M.

Based on Leelyn Smith's 13F filing for Q1 2021, filed 5 May 2021.